132 related articles for article (PubMed ID: 38551560)
1. Reports of COVID-19 Vaccine Adverse Events in Predominantly Republican vs Democratic States.
Asch DA; Luo C; Chen Y
JAMA Netw Open; 2024 Mar; 7(3):e244177. PubMed ID: 38551560
[TBL] [Abstract][Full Text] [Related]
2. Sex and gender differences in adverse events following influenza and COVID-19 vaccination.
Yin A; Wang N; Shea PJ; Rosser EN; Kuo H; Shapiro JR; Fenstermacher KZJ; Pekosz A; Rothman RE; Klein SL; Morgan R
Biol Sex Differ; 2024 Jun; 15(1):50. PubMed ID: 38890702
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
Front Immunol; 2021; 12():669010. PubMed ID: 34093567
[TBL] [Abstract][Full Text] [Related]
4. Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic.
Wallace J; Goldsmith-Pinkham P; Schwartz JL
JAMA Intern Med; 2023 Sep; 183(9):916-923. PubMed ID: 37486680
[TBL] [Abstract][Full Text] [Related]
5. Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
Moro PL; Ennulat C; Brown H; Woody G; Zhang B; Marquez P; Woo EJ; Su JR
Drug Saf; 2024 May; 47(5):487-493. PubMed ID: 38411838
[TBL] [Abstract][Full Text] [Related]
6. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
Moro PL; Zhang B; Ennulat C; Harris M; McVey R; Woody G; Marquez P; McNeil MM; Su JR
Vaccine; 2023 Mar; 41(11):1859-1863. PubMed ID: 36669964
[TBL] [Abstract][Full Text] [Related]
7. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Moro PL; Olson CK; Clark E; Marquez P; Strid P; Ellington S; Zhang B; Mba-Jonas A; Alimchandani M; Cragan J; Moore C
Vaccine; 2022 May; 40(24):3389-3394. PubMed ID: 35489985
[TBL] [Abstract][Full Text] [Related]
8. Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysis.
Warraich HJ; Kumar P; Nasir K; Joynt Maddox KE; Wadhera RK
BMJ; 2022 Jun; 377():e069308. PubMed ID: 35672032
[TBL] [Abstract][Full Text] [Related]
9. Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports.
Riad A; Põld A; Kateeb E; Attia S
Front Public Health; 2022; 10():952781. PubMed ID: 35899169
[TBL] [Abstract][Full Text] [Related]
10. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
[TBL] [Abstract][Full Text] [Related]
11. Independent Relationship of Changes in Death Rates with Changes in US Presidential Voting.
Goldman L; Lim MP; Chen Q; Jin P; Muennig P; Vagelos A
J Gen Intern Med; 2019 Mar; 34(3):363-371. PubMed ID: 30187378
[TBL] [Abstract][Full Text] [Related]
12. Oral adverse events following COVID-19 and influenza vaccination in Australia.
Riad A; Issa J; Attia S; Dušek L; Klugar M
Hum Vaccin Immunother; 2023 Aug; 19(2):2253589. PubMed ID: 37734344
[TBL] [Abstract][Full Text] [Related]
13. Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
Day B; Menschik D; Thompson D; Jankosky C; Su J; Moro P; Zinderman C; Welsh K; Dimova RB; Nair N
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):763-772. PubMed ID: 36813704
[TBL] [Abstract][Full Text] [Related]
14. Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States.
Sonawane K; Lin YY; Damgacioglu H; Zhu Y; Fernandez ME; Montealegre JR; Cazaban CG; Li R; Lairson DR; Lin Y; Giuliano AR; Deshmukh AA
JAMA Netw Open; 2021 Sep; 4(9):e2124502. PubMed ID: 34533574
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.
Haas JW; Bender FL; Ballou S; Kelley JM; Wilhelm M; Miller FG; Rief W; Kaptchuk TJ
JAMA Netw Open; 2022 Jan; 5(1):e2143955. PubMed ID: 35040967
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
[TBL] [Abstract][Full Text] [Related]
17. Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.
Moro PL; Harrington T; Shimabukuro T; Cano M; Museru OI; Menschik D; Broder K
Vaccine; 2013 Oct; 31(43):4984-7. PubMed ID: 23994022
[TBL] [Abstract][Full Text] [Related]
18. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
Geier DA; King PG; Sykes LK; Geier MR
Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS).
Zhang B; Yu X; Liu J; Liu J; Liu P
BMC Womens Health; 2022 Oct; 22(1):403. PubMed ID: 36195902
[TBL] [Abstract][Full Text] [Related]
20. The Association of COVID-19 Infection and Vaccination Rates in Florida.
Bernet P
J Public Health Manag Pract; 2022 Jul-Aug 01; 28(4):E676-E684. PubMed ID: 35149660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
